Veronika Sexl

Professor, Head of Institute

Vetmeduni

Austria

Research Interests

Explore related searches

Professors in Austria Professors in Immunology Immunology professors in Austria

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Veronika Sexl is the Head of Institute at VetmedUni in Austria. Her research focuses on hematological malignancies, with recent publications addressing the roles of CDK6 and JAK inhibitors in cancer treatment, as well as the influence of microbiota on immune responses. She also investigates the biology of hematopoietic stem/progenitor cells and their implications in leukemia management.

Articles (10)

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (7)

Olaf Merkel

Associate Prof. Dr.

Medical University of Vienna

AUSTRIA

View details

Zoe Waibler

Paul-Ehrlich-Institut

GERMANY

View details

Karoline Kollmann

University of Veterinary Medicine Vienna

AUSTRIA

View details

Frank Michael Lehmann

SWITZERLAND

View details

Christoph Mueller

Professor

University of Bern

SWITZERLAND

View details

Daniela Finke

Professor

University of Basel

SWITZERLAND

View details

Gerwin Heller

Medical University of Vienna

AUSTRIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Veronika Sexl

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

CDK6 Degradation Is Counteracted by p16<sup>INK4A</sup> and p18<sup>INK4C</sup> in AML

Isolation, Maintenance and Expansion of Adult Hematopoietic Stem/Progenitor Cells and Leukemic Stem Cells

Untwining Anti-Tumor and Immunosuppressive Effects of JAK Inhibitors—A Strategy for Hematological Malignancies?

Microbiota-induced tissue signals regulate ILC3-mediated antigen presentation

CDK4/6 and MAPK—Crosstalk as Opportunity for Cancer Treatment

CDK6 Inhibition: A Novel Approach in AML Management

Selective reconstitution of IFN‑γ gene function in Ncr1+ NK cells is sufficient to control systemic vaccinia virus infection

High activation of STAT5A drives peripheral T-cell lymphoma and leukemia

Phospho-Profiling Linking Biology and Clinics in Pediatric Acute Myeloid Leukemia

Human signal transducer and activator of transcription 5b (STAT5b) mutation causes dysregulated human natural killer cell maturation and impaired lytic function

Collaborators (7)

Olaf Merkel

Zoe Waibler

Karoline Kollmann

Frank Michael Lehmann

Christoph Mueller

Daniela Finke

Gerwin Heller

Make your next move.